Literature DB >> 12126839

Minimal residual disease evaluation in acute myeloid leukaemia.

John A Liu Yin1, David Grimwade.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12126839     DOI： 10.1016/S0140-6736(02)09419-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  Nanodevices in diagnostics.

Authors:  Ye Hu; Daniel H Fine; Ennio Tasciotti; Ali Bouamrani; Mauro Ferrari
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2011 Jan-Feb

Review 2.  Minimal residual disease quantitation in acute myeloid leukemia.

Authors:  David Shook; Elaine Coustan-Smith; Raul C Ribeiro; Jeffrey E Rubnitz; Dario Campana
Journal:  Clin Lymphoma Myeloma       Date:  2009

3.  Leukemia associated antigens: their dual role as biomarkers and immunotherapeutic targets for acute myeloid leukemia.

Authors:  Barbara-Ann Guinn; Azim Mohamedali; Ken I Mills; Barbara Czepulkowski; Michael Schmitt; Jochen Greiner
Journal:  Biomark Insights       Date:  2007-02-14

4.  Monitoring AML1-ETO and CBFbeta-MYH11 transcripts in acute myeloid leukemia.

Authors:  John A Liu Yin; Lindsay Frost
Journal:  Curr Oncol Rep       Date:  2003-09       Impact factor: 5.075

Review 5.  Aptamers from cell-based selection for bioanalytical applications.

Authors:  Weihong Tan; Michael J Donovan; Jianhui Jiang
Journal:  Chem Rev       Date:  2013-03-19       Impact factor: 60.622

6.  Clinical analysis and optimization of postremission therapy for acute myeloid leukemia patients with minimal residual disease as determined by flow cytometry.

Authors:  Daichi Inoue; Hayato Maruoka; Takayuki Takahashi
Journal:  Mediterr J Hematol Infect Dis       Date:  2010-08-05       Impact factor: 2.576

7.  Minimal residual disease as a predictive factor for relapse after allogeneic hematopoietic stem cell transplant in adult patients with acute myeloid leukemia in first and second complete remission.

Authors:  Rada M Grubovikj; Asif Alavi; Ahrin Koppel; Mary Territo; Gary J Schiller
Journal:  Cancers (Basel)       Date:  2012-06-20       Impact factor: 6.639

8.  Intravenous Vitamin C Administration Improved Blood Cell Counts and Health-Related Quality of Life of Patient with History of Relapsed Acute Myeloid Leukaemia.

Authors:  Mike N Foster; Anitra C Carr; Alina Antony; Selene Peng; Mike G Fitzpatrick
Journal:  Antioxidants (Basel)       Date:  2018-07-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.